Actualités Mei Pharma, Inc. (MM) - MSHL | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-179590 Prospectus Supplement...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP") New Name and Ticker Symbol Effective Monday, July 2, 2012 PR Newswire SAN DIEGO...

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-179590 Prospectus Supplement No. 4 (to Prospectus dated March 26...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143 Data Presented at the American Society of Clinical...

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 PR Newswire SAN DIEGO, May...

- Amended Statement of Beneficial Ownership (SC 13D/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Information To Be...

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

Table of Contents Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-179590 Prospectus Supplement No. 3 (to Prospectus dated...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ...

Marshall Edwards Completes Rights Offering To Stockholders

Marshall Edwards Completes Rights Offering To Stockholders PR Newswire SAN DIEGO, May 14, 2012 SAN DIEGO, May 14, 2012 /PRNewswire/ -- Marshall...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Mei Pharma, Inc. (MM) (MSHL)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

MSHL Actualités

- Statement of Changes in Beneficial Ownership (4)

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Current report filing (8-K)

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Current report filing (8-K)

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344

- Amended Statement of Beneficial Ownership (SC 13D/A)

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Quarterly Report (10-Q)

Marshall Edwards Completes Rights Offering To Stockholders

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Mei Pharma, Inc. (MM) (MSHL) Actualités

Mei Pharma, Inc. (MM) (MSHL)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

MSHL Actualités

- Statement of Changes in Beneficial Ownership (4)

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Current report filing (8-K)

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Current report filing (8-K)

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344

- Amended Statement of Beneficial Ownership (SC 13D/A)

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Quarterly Report (10-Q)

Marshall Edwards Completes Rights Offering To Stockholders

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités